STOCK TITAN

Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Harrow Health, Inc. (Nasdaq: HROW) will release its financial results for Q2 ended June 30, 2022 on August 9, 2022, after market close. A Letter to Stockholders will be available on its website. Following this, a conference call will occur at 4:45 p.m. ET to discuss the results and provide a business update. Investors can participate through dial-in or via live webcast. The telephonic replay will be available until August 16, 2022, and the webcast replay until November 9, 2022.

Positive
  • None.
Negative
  • None.

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable, today announced that it will release its financial results for the second quarter ended June 30, 2022, on Tuesday, August 9, 2022, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow Health will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update.

Conference Call Details:

 

Date:

Tuesday, August 9, 2022

Time:

4:45 p.m. Eastern time

Participant Dial-in:

1-833-953-2434 (U.S.)

1-412-317-5763 (International)

Replay Dial-in (Passcode 8466369):

(telephonic replay through August 16, 2022)

1-877-344-7529 (U.S.)

1-412-317-0088 (International)

Webcast: (online replay through November 9, 2022)

harrowinc.com

 

About Harrow Health
Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com.

Jamie Webb, Director of Communications and Investor Relations

jwebb@harrowinc.com

615-733-4737

Source: Harrow Health, Inc.

FAQ

When will Harrow Health release its Q2 2022 financial results?

Harrow Health will release its Q2 2022 financial results on August 9, 2022, after market close.

What time is the Harrow Health conference call for Q2 results?

The conference call will take place at 4:45 p.m. Eastern Time on August 9, 2022.

How can I access the Harrow Health Q2 2022 financial results?

The financial results will be posted on Harrow Health's website in the Investors section.

Will there be a replay available for the Harrow Health conference call?

Yes, a telephonic replay will be available until August 16, 2022, and the webcast replay until November 9, 2022.

Harrow, Inc.

NASDAQ:HROW

HROW Rankings

HROW Latest News

HROW Stock Data

1.27B
30.81M
13.49%
59.29%
8.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
NASHVILLE